AKRO - Akero Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AKRO is currently covered by 8 analysts with an average price target of $63.71. This is a potential upside of $26.98 (73.45%) from yesterday's end of day stock price of $36.73.

Akero Therapeutics's activity chart (see below) currently has 44 price targets and 74 ratings on display. The stock rating distribution of AKRO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.06% with an average time for these price targets to be met of 343.33 days.

Highest price target for AKRO is $109, Lowest price target is $38, average price target is $67.14.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 03-Mar-2025. First documented stock forecast 15-Jul-2019.

Currently out of the existing stock ratings of AKRO, 41 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$75

$38.27 (104.19%)

$72

1 months 2 days ago
(03-Mar-2025)

12/25 (48%)

$29.46 (64.69%)

266

Buy

$109

$72.27 (196.76%)

$42

2 months 5 days ago
(31-Jan-2025)

2/4 (50%)

$54.92 (101.55%)

401

Buy

$73

$36.27 (98.75%)

$56

2 months 8 days ago
(28-Jan-2025)

5/8 (62.5%)

$21.53 (41.83%)

450

Buy

$96

$59.27 (161.37%)

$46

2 months 8 days ago
(28-Jan-2025)

3/6 (50%)

$44.53 (86.52%)

350

Buy

9 months 16 days ago
(20-Jun-2024)

1/4 (25%)

$29.93 (96.33%)

474

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AKRO (Akero Therapeutics) average time for price targets to be met?

On average it took 343.33 days on average for the stock forecasts to be realized with a an average price target met ratio 60.06

Which analyst has the current highest performing score on AKRO (Akero Therapeutics) with a proven track record?

EDWARD NASH

Which analyst has the current lower performing score on AKRO (Akero Therapeutics) with a proven track record?

PRAKHAR AGRAWAL

Which analyst has the most public recommendations on AKRO (Akero Therapeutics)?

Edward Nash works at CANACCORD and has 23 price targets and 12 ratings on AKRO

Which analyst is the currently most bullish on AKRO (Akero Therapeutics)?

Eliana Merle with highest potential upside - $72.27

Which analyst is the currently most reserved on AKRO (Akero Therapeutics)?

Matthew Harrison with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?